Left Menu
Development News Edition

Glenmark Pharma to launch clinical trial in solid tumors for anti-myeloma drug

Glenmark Pharma said the decision to launch clinical trial is driven by recent findings derived from a non-interventional human study.


Glenmark Pharma to launch clinical trial in solid tumors for anti-myeloma drug

Glenmark Pharmaceuticals Thursday said it will launch phase 1 trial in solid tumours for its bispecific antibody GBR 1342, indicated for the treatment of multiple myeloma.

"The company intends to file an Investigational New Drug (IND) application for GBR 1342 in solid tumours and initiate a clinical trial in 2019," the company said in a regulatory filing.

Glenmark Pharma said the decision to launch a clinical trial is driven by recent findings derived from a non-interventional human study.

"Our work with innovative immunotherapeutics such as T cell re-directing bispecific antibodies necessitates detailed analyses to fully understand and assess the potential opportunities presented by the candidates in our pipeline," said Kurt Stoeckli, President and Chief Scientific Officer at Glenmark Pharmaceuticals.

An ongoing first-in-human, open-label, phase 1 trial of GBR 1342 in multiple myeloma, is assessing the safety and tolerability of increasing doses of GBR 1342, and will also evaluate biomarkers, immunogenicity, and additional measures of disease activity, it added.

Glenmark said GBR 1342 is one of three investigational immuno-oncology agents based on Glenmark's proprietary BEAT (Bispecific Engagement by Antibodies based on the T cell receptor) platform.

(With inputs from agencies.)

Download The Devdiscourse News App for Latest News.


TRENDING

OPINION/BLOG/INTERVIEW

Top 10 Fake News, Myths and Realities on 2019 Novel Coronavirus COVID 19

With nearly 1500 deaths by January 14 and around 65,000 infections in China, the Novel Coronavirus 2019 has become one of the worst health epidemics of the 21st Century. However, 8,573 people have been cured but the rumor mongers are a...

Handling fake news Infodemic in time of Coronavirus epidemic

Social media has provided a platform where everybody can disseminate his her views without any supervision. Its excellent if the message is genuine but misinformation is equally disastrous. Health is such a topic where every Tom and Harry c...

Sentiment Analysis on Budget 2020: Long shot for solution to economic worries?

Industries and individuals alike had high expectations from the government to take tangible steps but the budget 2020 seems to have failed expectations....

How can technology help the future of mobility?

More than a billion people or one-third of the global rural population lacked access to all-season roads and transport services in 2016, subsequently hindering the socio-economic development....

Videos

Latest News

UPDATE 1-British TV presenter Flack died by hanging, inquest hears

British television presenter Caroline Flack was found hanged in her London flat on Saturday and paramedics were unable to revive her, an inquest into her death heard.The suicide of the 40-year-old former presenter of the hugely popular Love...

Nokia, Japan's Odakyu join forces for AI-based railroad crossing safety trials

Nokia has partnered with Odakyu Electric Railway, one of the leading private railway operators in Japan, to carry out AI-based railroad crossing safety trials.The trial which is already underway at Tamagawa Gakuenmae No.8 railroad crossing ...

Italy govt wins lower house confidence vote on new motorway rules

The Italian government on Wednesday won a confidence vote in the lower house of parliament on a decree which includes new rules that make it easier and less costly for the state to revoke motorway concessions.The move comes as the ruling co...

Himachal: CM Thakur, Union minister lay stones of projects worth Rs 40 crore

Chief Minister Jai Ram Thakur and Union minister Anurag Thakur laid the foundation stones of development projects worth Rs 40 crore in the Dehra assembly constituency of Himachal Pradesh on Wednesday. Among the projects whose foundation sto...

Give Feedback